• How we work
    • Software
    • Smarts
    • Service
  • Solutions
    • Mapping
    • Measuring
    • Monitoring
  • Insights
    • Latest thinking
    • Resources
  • About
    • Who we are
    • Team
    • Careers
    • Contact us
  • Client login
Apple’s intelligent AI move: Can a second-mover strategy pay off?

Apple’s intelligent AI move: Can a second-mover strategy pay off?

by Georgi Ivanov | Jun 18, 2024 | Blog

Apple’s long-awaited entry into the AI race at its 2024 Worldwide Developers Conference has ignited a fierce debate in the tech world. The unveiling of Apple Intelligence (AI), a new generative AI suite that harnesses user data from Apple devices to provide...
Offshore wind’s future is a PR battle against misinformation. How to win it?

Offshore wind’s future is a PR battle against misinformation. How to win it?

by James Robbins | Jun 17, 2024 | Blog

The success of offshore wind power depends on winning a battle against false narratives, which requires energy companies to tailor their communication strategies to diverse audience segments. The problem: We noticed the signs a year ago, but now it’s clear –...
The ASCO 2024 narrative shift: In oncology, less is becoming more

The ASCO 2024 narrative shift: In oncology, less is becoming more

by Georgi Ivanov | Jun 10, 2024 | Blog

ASCO’s focus on less invasive treatment suggests a narrative shift in oncology: that doing less — less surgery, less chemotherapy or less radiation — can help patients live longer and feel better. The context: The 2024 edition of the American Society of Clinical...
All talk, no trust: Why consumers don’t (yet) buy into AI in finance

All talk, no trust: Why consumers don’t (yet) buy into AI in finance

by Alan Walker | May 28, 2024 | Blog

The financial services industry talks a big game about its use of AI, but our analysis reveals that this talk remains vague and fails to address emerging consumer privacy concerns. The problem: In the UK, 50% of consumers say they don’t feel comfortable with their...
Novo Nordisk changed the obesity debate. But its reputation is on the line

Novo Nordisk changed the obesity debate. But its reputation is on the line

by Maya Koleva | Mar 13, 2024 | Blog

Reading time: 3 min While Wegovy reshaped public attitudes about obesity, its maker Novo Nordisk oversaw critical reputational threats, highlighting that product success alone cannot safeguard pharma companies without a comprehensive, data-driven reputation management...
Prev12345Next

Recent Posts

  • When is a Newsletter NOT a Newsletter?
  • Commetric shortlisted for two DataComms Awards 2025
  • Commetric Announces Leadership Changes: Solheim as Non-Executive Chairman, Minkovski as Interim CEO
  • From product to process: how the FMCG sustainability communications evolved
  • The road to IPO: how fintechs are building new maturity narratives

Tags

AI AMEC Brand management Climate Change Consumer Trends Corporate Communication Corporate Reputation COVID-19 Business Impact Tracker Crisis Communications Crisis Management Digital Marketing Diversity and Inclusion ESG Fashion Financial Services Food and Drink Health & Wellness Health and Wellness Immunotherapy Influencer Marketing Influencer Network Analysis Media Analytics Media Intelligence Media Monitoring Net Zero Oncology Pharma PR PR Analytics Precision Medicine PR Measurement PR Strategy Public Affairs Public Relations Regeneration Reputation Management Social Media Social Media Analytics Social Media Marketing Sports Strategic Communications Sustainability Tech Technology Twitter

How we work

Software

Smarts

Service

Solutions

Mapping

Measuring

Monitoring

Information

Insights

Resources

Who we are

Team

Careers

Privacy Policy

GDPR Policy

Contact

E-mail:
info@commetric.com

Phone:
+44 (0) 845 287 3003

  • Follow
  • Follow
Copyright ©2025 Commetric